Home
Reels
Groups
Pages
See More
Groups Pages Events Blogs Funding
Sign In Sign Up
Night Mode
Triple-Negative Breast Cancer: The Frontline of Innovation in HER2 Negative Disease
Within the HER2 negative breast cancer category, triple-negative breast cancer (TNBC) stands out as the most aggressive and historically most challenging subtype. Lacking estrogen receptors, progesterone receptors, and HER2 expression, TNBC doesn't respond to targeted therapies that benefit other breast cancer types, leaving chemotherapy as the mainstay for decades. That's changing...
0 Comments ·0 Shares ·13 Views ·0 Reviews
Please log in to like, share and comment!